ZA200406715B - Compositions and methods for promoting lipid mobilization glycogen mobilization or both in humans - Google Patents
Compositions and methods for promoting lipid mobilization glycogen mobilization or both in humansInfo
- Publication number
- ZA200406715B ZA200406715B ZA200406715A ZA200406715A ZA200406715B ZA 200406715 B ZA200406715 B ZA 200406715B ZA 200406715 A ZA200406715 A ZA 200406715A ZA 200406715 A ZA200406715 A ZA 200406715A ZA 200406715 B ZA200406715 B ZA 200406715B
- Authority
- ZA
- South Africa
- Prior art keywords
- mobilization
- humans
- compositions
- methods
- glycogen
- Prior art date
Links
- 229920002527 Glycogen Polymers 0.000 title 1
- 229940096919 glycogen Drugs 0.000 title 1
- 150000002632 lipids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5061—Muscle cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5067—Liver cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/072,419 US6852693B2 (en) | 2002-02-07 | 2002-02-07 | Compositions and methods for promoting lipid mobilization in humans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200406715B true ZA200406715B (en) | 2006-06-28 |
Family
ID=27732307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200406715A ZA200406715B (en) | 2002-02-07 | 2004-08-24 | Compositions and methods for promoting lipid mobilization glycogen mobilization or both in humans |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US6852693B2 (enExample) |
| EP (1) | EP1480668A1 (enExample) |
| JP (1) | JP2005516996A (enExample) |
| AU (1) | AU2003210923A1 (enExample) |
| CA (1) | CA2474203A1 (enExample) |
| WO (1) | WO2003066080A1 (enExample) |
| ZA (1) | ZA200406715B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852693B2 (en) * | 2002-02-07 | 2005-02-08 | Blm Group | Compositions and methods for promoting lipid mobilization in humans |
| US20050214275A1 (en) * | 2004-01-02 | 2005-09-29 | Gross Richard W | Sequential ordered fatty acid alpha oxidation and delta9 desaturation are major determinants of lipid storage and utilization in adipocytes |
| US20050222040A1 (en) * | 2004-04-05 | 2005-10-06 | Blm Group, Inc. | Vertebrate peptide modulators of lipid metabolism |
| JP4688483B2 (ja) * | 2004-04-15 | 2011-05-25 | 株式会社テクノネットワーク四国 | フォリスタチン変異体ポリペプチド |
| WO2010051347A1 (en) * | 2008-10-31 | 2010-05-06 | David Sheikh-Hamad | A method for cardioprotection |
| CA2751612A1 (en) * | 2009-02-06 | 2010-08-12 | The Regents Of The University Of California | Calcium-binding agents induce hair growth and/or nail growth |
| WO2016153453A1 (en) | 2015-03-26 | 2016-09-29 | Mutlu Oguz | Therapeutic use of adipokinetic hormone/red pigment-concentrating hormone (akh/rpch) family of peptides |
| TR201712479A2 (tr) | 2017-08-22 | 2019-05-21 | Oguz Mutlu | Adi̇poki̇neti̇k hormon/kirmizi pi̇gment-konsantre edi̇ci̇ hormon (akh/rpch) pepti̇t ai̇lesi̇ni̇n yeni̇ terapöti̇k kullanimlari |
| KR102380291B1 (ko) * | 2020-06-15 | 2022-03-29 | 대한민국 | 풀무치 추출물을 포함하는 비만 예방 또는 치료용 조성물 |
| KR102380290B1 (ko) * | 2020-06-15 | 2022-03-29 | 대한민국 | 아메리카왕거저리 유충 추출물을 포함하는 비만 예방 또는 치료용 조성물 |
| GB202215797D0 (en) | 2022-10-25 | 2022-12-07 | Solasta Bio Ltd | Insect neuropeptide analogues |
| US12245596B1 (en) | 2023-10-23 | 2025-03-11 | Solasta Bio Limited | Insect neuropeptides 8 |
| US12302908B2 (en) | 2023-10-23 | 2025-05-20 | Solasta Bio Limited | Insect neuropeptides 4 |
| US12356995B2 (en) | 2023-10-23 | 2025-07-15 | Solasta Bio Limited | Insect neuropeptides 9 |
| EP4570072A3 (en) * | 2023-10-23 | 2025-07-02 | Solasta Bio Limited | Insect neuropeptides 8 |
| US12279621B1 (en) | 2023-10-23 | 2025-04-22 | Solasta Bio Limited | Insect neuropeptides 3 |
| US12281143B1 (en) | 2023-10-23 | 2025-04-22 | Solasta Bio Limited | Insect neuropeptides 1 |
| US12245588B1 (en) | 2023-10-23 | 2025-03-11 | Solasta Bio Limited | Insect neuropeptides 2 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260601A (en) | 1979-10-23 | 1981-04-07 | Nyegaard & Co. A/S | Chemical compounds |
| US4328134A (en) | 1980-05-06 | 1982-05-04 | Schally Andrew Victor | Anorexigenic peptides |
| US4464356A (en) | 1982-05-07 | 1984-08-07 | Mordes John P | Anorexigenic composition and method |
| US4489059A (en) | 1982-05-07 | 1984-12-18 | Rossini Aldo A | Anorexigenic composition and method |
| US4891219A (en) | 1986-03-14 | 1990-01-02 | Aphton Corporation | Method for immunization against and treatment of infection by ectoparasites and endoparasites |
| GB8806471D0 (en) | 1988-03-18 | 1988-04-20 | Tisdale M J | Biologically active material characterised by catabolic activity generally associated with cachexia inducing tumours |
| US5616311A (en) * | 1991-01-15 | 1997-04-01 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
| FR2710340B1 (fr) | 1993-09-22 | 1995-12-15 | D Hinterland Lucien Dussourd | Dérivés peptidiques de l'alpha-MSH et leur application . |
| FR2767135B1 (fr) | 1997-08-06 | 2002-07-12 | Genset Sa | Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes |
| US6852693B2 (en) * | 2002-02-07 | 2005-02-08 | Blm Group | Compositions and methods for promoting lipid mobilization in humans |
-
2002
- 2002-02-07 US US10/072,419 patent/US6852693B2/en not_active Expired - Fee Related
-
2003
- 2003-02-07 EP EP03737707A patent/EP1480668A1/en not_active Withdrawn
- 2003-02-07 AU AU2003210923A patent/AU2003210923A1/en not_active Abandoned
- 2003-02-07 CA CA002474203A patent/CA2474203A1/en not_active Abandoned
- 2003-02-07 WO PCT/US2003/003800 patent/WO2003066080A1/en not_active Ceased
- 2003-02-07 JP JP2003565503A patent/JP2005516996A/ja not_active Withdrawn
-
2004
- 2004-06-16 US US10/869,768 patent/US7314865B2/en not_active Expired - Fee Related
- 2004-08-24 ZA ZA200406715A patent/ZA200406715B/xx unknown
-
2007
- 2007-10-19 US US11/975,735 patent/US8067363B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040224898A1 (en) | 2004-11-11 |
| AU2003210923A1 (en) | 2003-09-02 |
| CA2474203A1 (en) | 2003-08-14 |
| JP2005516996A (ja) | 2005-06-09 |
| US7314865B2 (en) | 2008-01-01 |
| US20090036383A1 (en) | 2009-02-05 |
| US8067363B2 (en) | 2011-11-29 |
| US6852693B2 (en) | 2005-02-08 |
| US20030162717A1 (en) | 2003-08-28 |
| WO2003066080A1 (en) | 2003-08-14 |
| EP1480668A1 (en) | 2004-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200406715B (en) | Compositions and methods for promoting lipid mobilization glycogen mobilization or both in humans | |
| EP1697642A4 (en) | FASTENING ELEMENTS AND OTHER ARRANGEMENTS | |
| AU2002334894A1 (en) | Compositions and methods for promoting nematode resistance in plants | |
| PT2286663T (pt) | Métodos e composições para tratar infestação de ectoparasitas | |
| AU2003297037A8 (en) | Illuminant and method | |
| GB0411940D0 (en) | Methods and compositions | |
| EP1701725A4 (en) | PROCESS AND COMPOSITIONS | |
| IL163876A0 (en) | Therapeutic methods and compositions involving isovlav-3-ene and isoflavan structures | |
| TWI348479B (en) | Impact-modified compositions and method | |
| EP1684771A4 (en) | COMPOSITION AND METHOD | |
| GB0221306D0 (en) | Psychological stress in humans | |
| GB0324756D0 (en) | Article and method | |
| ZA200602374B (en) | Article and method | |
| AU2002346446A8 (en) | Methods and compositions in checkpoint signaling | |
| EP1583557A4 (en) | VACCINE COMPOSITIONS AND METHODS | |
| AU2003225710A8 (en) | Composition and method for enhancing immune response | |
| GB0424297D0 (en) | Fastener in the form of an eyebolt | |
| AU2003245524A8 (en) | Cryosurgery compositions and methods | |
| GB0312747D0 (en) | Products and methods | |
| AU2003228378A1 (en) | Herbal compositions and methods for effecting weight loss in humans | |
| AU2003904281A0 (en) | Improvements in or relating to insulating materials and methods | |
| GB0229293D0 (en) | Composition and method | |
| GB0211889D0 (en) | Composition and method | |
| GB0211220D0 (en) | Composition and method | |
| GB0211116D0 (en) | Composition and method |